BerandaBEAM • NASDAQ
add
Beam Therapeutics Inc
$17,00
Setelah Jam Perdagangan Normal:(0,00%)0,00
$17,00
Tutup: 17 Apr, 16.32.33 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$16,62
Rentang hari
$16,49 - $17,20
Rentang tahun
$13,53 - $35,25
Kapitalisasi pasar
1,70Â M USD
Volume Rata-Rata
2,93Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 30,07Â jt | -90,49% |
Biaya operasional | 28,66Â jt | -33,74% |
Laba bersih | -90,35Â jt | -163,27% |
Margin laba bersih | -300,51 | -765,43% |
Penghasilan per saham | -1,09 | -163,01% |
EBITDA | -94,59Â jt | -168,44% |
Tarif pajak efektif | 0,00% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 850,74Â jt | -28,50% |
Total aset | 1,10Â M | -24,38% |
Total liabilitas | 370,28Â jt | -22,60% |
Total ekuitas | 733,54 jt | — |
Saham yang beredar | 81,11 jt | — |
Harga terhadap nilai buku | 1,84 | — |
Tingkat pengembalian aset | -21,98% | — |
Tingkat pengembalian modal | -27,06% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -90,35Â jt | -163,27% |
Kas dari operasi | -76,36Â jt | -156,54% |
Kas dari investasi | 126,28Â jt | 28,73% |
Kas dari pembiayaan | 3,44Â jt | -89,78% |
Perubahan kas bersih | 53,36Â jt | -80,01% |
Arus kas bebas | -22,18Â jt | -123,15% |
Tentang
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducing the likelihood of off-target effects compared to previous CRISPR-based methods. Wikipedia
CEO
Didirikan
2017
Situs
Karyawan
483
